Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT
Tweet
Share
E-mailGet Alerts ITMN Hot Sheet
Price: $73.89 --0%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on InterMune Inc. (NASDAQ: ITMN) price target lowered from $24 to $15.
Analyst, Ritu Baral, said, "Reiterate rating, lowering target to $15 on lower, but still blockbuster, Esbriet (pirfenidone) sales prospects. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis (IPF), an orphan lung disease. We see good Esbriet EU potential (despite price concerns) and encouraging 2012 adoption, but are reducing our worldwide peak sales estimate to $2.1B from $3.6B in 2025."
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $10.08 yesterday.
Analyst, Ritu Baral, said, "Reiterate rating, lowering target to $15 on lower, but still blockbuster, Esbriet (pirfenidone) sales prospects. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis (IPF), an orphan lung disease. We see good Esbriet EU potential (despite price concerns) and encouraging 2012 adoption, but are reducing our worldwide peak sales estimate to $2.1B from $3.6B in 2025."
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $10.08 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Into EPS
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
